Abstract
Purpose
Blood-brain barrier disruption (BBBD) is of interest for treating neurodegenerative diseases and tumors by enhancing drug delivery. Focused ultrasound (FUS) is a powerful method to alleviate BBB challenges; however, the detection of BBB opening by non-invasive methods remains limited. The purpose of this work is to demonstrate that 3D transcranial color Doppler (3DCD) and photoacoustic imaging (PAI) combined with custom-made nanoparticle (NP)-mediated FUS delivery can detect BBBD in mice.
Procedures
We use MRI and stereotactic ultrasound-mediated BBBD to create and confirm four openings in the left hemisphere and inject intravenously indocyanine green (ICG) and three sizes (40 nm, 100 nm, and 240 nm in diameter) of fluorophore-labeled NPs. We use PAI and fluorescent imaging (FI) to assess the spatial distribution of ICG/NPs in tissues.
Results
A reversible 41 ± 12 % (n = 8) decrease in diameter of the left posterior cerebral artery (PCA) relative to the right after FUS treatment is found using CD images. The spectral unmixing of photoacoustic images of the in vivo (2 h post FUS), perfused, and ex vivo brain reveals a consistent distribution pattern of ICG and NPs at *FUS locations. Ex vivo spectrally unmixed photoacoustic images show that the opening width is, on average, 1.18 ± 0.12 mm and spread laterally 0.49 ± 0.05 mm which correlated well with the BBB opening locations on MR images. In vivo PAI confirms a deposit of NPs in tissues for hours and potentially days, is less sensitive to NPs of lower absorbance at a depth greater than 3 mm and too noisy with NPs above an absorbance of 85.4. FI correlates well with ex vivo PAI to a depth of 3 mm in tissues for small NPs and 4.74 mm for large NPs.
Conclusions
3DCD can monitor BBBD over time by detecting reversible anatomical changes in the PCA. In vivo 3DPAI at 15 MHz combined with circulating ICG and/or NPs with suitable properties can assess BBB opening 2 h post FUS.
This is a preview of subscription content, access via your institution.






References
Gonzales-Portillo GS, Sanberg PR, Franzblau M, Gonzales-Portillo C, Diamandis T, Staples M, Sanberg CD, Borlongan CV (2014) Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier. Cell Transplant 23:531–539
Lee HJ, Zhang Y, Pardridge WM (2002) Blood-brain barrier disruption following the internal carotid arterial perfusion of alkyl glycerols. J Drug Target 10:463–467
Black KL, Cloughesy T, Huang S-C, Gobin YP, Zhou Y, Grous J, Nelson G, Farahani K, Hoh CK, Phelps M (1997) Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 86:603–609
Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC (2007) Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 337:1–24
Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614–628
Goldsmith M, Abramovitz L, Peer D (2014) Precision nanomedicine in neurodegenerative diseases. ACS Nano 8:1958–1965
Patel T, Zhou J, Piepmeier JM, Saltzman WM (2012) Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 64:701–705
Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2–14
Stockwell J, Abdi N, Lu X, Maheshwari O, Taghibiglou C (2014) Novel central nervous system drug delivery systems. Chem Biol Drug Des 83:507–520
Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L (2016) Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 235:34–47
Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220:640–646
O’Reilly MA, Hynynen K (2012) Ultrasound enhanced drug delivery to the brain and central nervous system. Int J Hyperth 28:386–396
Miller DB, O’Callaghan JP (2017) New horizons for focused ultrasound (FUS) – therapeutic applications in neurodegenerative diseases. Metabolism 69:S3–S7
Park E-J, Zhang Y-Z, Vykhodtseva N, McDannold N (2012) Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 163:277–284
Park J, Aryal M, Vykhodtseva N, Zhang YZ, McDannold N (2017) Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J Control Release 250:77–85
Cho EE, Drazic J, Ganguly M, Stefanovic B, Hynynen K (2011) Two-photon fluorescence microscopy study of cerebrovascular dynamics in ultrasound-induced blood-brain barrier opening. J Cereb Blood Flow Metab 31:1852–1862
Burgess A, Nhan T, Moffatt C, Klibanov AL, Hynynen K (2014) Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer’s disease using two-photon microscopy. J Control Release 192:243–248
Zhao Y-J, Yu T-T, Zhang C, Li Z, Luo QM, Xu TH, Zhu D (2018) Skull optical clearing window for in vivo imaging of the mouse cortex at synaptic resolution. Light Sci Appl 7:17153
Feng W, Zhang C, Yu T, et al (2018) In vivo monitoring blood-brain barrier permeability using spectral imaging through optical clearing skull window. J Biophotonics
Wu SY, Sanchez CS, Samiotaki G, Buch A, Ferrera VP, Konofagou EE (2016) Characterizing focused-ultrasound mediated drug delivery to the heterogeneous primate brain in vivo with acoustic monitoring. Sci Rep. https://doi.org/10.1038/srep37094
Wu SY, Aurup C, Sanchez CS, Grondin J, Zheng W, Kamimura H, Ferrera VP, Konofagou EE (2018) Efficient blood-brain barrier opening in primates with neuronavigation-guided ultrasound and real-time acoustic mapping. Sci Rep. https://doi.org/10.1038/s41598-018-25904-9
Wang P-H, Liu H-L, Hsu P-H, Lin CY, Chris Wang CR, Chen PY, Wei KC, Yen TC, Li ML (2012) Gold-nanorod contrast-enhanced photoacoustic micro-imaging of focused-ultrasound induced blood-brain-barrier opening in a rat model. J Biomed Opt 17:61222
Lu HD, Wilson BK, Heinmiller A, Faenza B, Hejazi S, Prud’homme RK (2016) Narrow absorption NIR wavelength organic nanoparticles enable multiplexed photoacoustic imaging. ACS Appl Mater Interfaces 8:14379–14388
Needles A, Heinmiller A, Sun J, Theodoropoulos C, Bates D, Hirson D, Yin M, Foster FS (2013) Development and initial application of a fully integrated photoacoustic micro-ultrasound system. IEEE Trans Ultrason Ferroelectr Freq Control 60:888–897
Luke GP, Nam SY, Emelianov SY (2013) Optical wavelength selection for improved spectroscopic photoacoustic imaging. Photoacoustics 1:36–42
Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N (2005) Local and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24:12–20
Lee S, Lim W, Ryu HW, Jo D, Min JJ, Kim HS, Hyun H (2017) ZW800-1 for assessment of blood-brain barrier disruption in a photothrombotic stroke model. Int J Med Sci 14:1430–1435
Razansky D, Buehler A, Ntziachristos V (2011) Volumetric real-time multispectral optoacoustic tomography of biomarkers. Nat Protoc 6:1121–1129
Kim C, Cho EC, Chen J, Song KH, Au L, Favazza C, Zhang Q, Cobley CM, Gao F, Xia Y, Wang LV (2010) In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. ACS Nano 4:4559–4564
Lu W, Huang Q, Ku G, Wen X, Zhou M, Guzatov D, Brecht P, Su R, Oraevsky A, Wang LV, Li C (2010) Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials 31:2617–2626
Pan D, Pramanik M, Senpan A, Allen JS, Zhang H, Wickline SA, Wang LV, Lanza GM (2011) Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons. FASEB J 25:875–882
Chen Y-S, Frey W, Kim S, Homan K, Kruizinga P, Sokolov K, Emelianov S (2010) Enhanced thermal stability of silica-coated gold nanorods for photoacoustic imaging and image-guided therapy. Opt Express 18:8867
Pansare VJ, Hejazi S, Faenza WJ, Prud’Homme RK (2012) Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores, and multifunctional nano carriers. Chem Mater 24:812–827
De la Zerda A, Zavaleta C, Keren S et al (2008) Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 3:557–562
Mallidi S, Larson T, Tam J, Joshi PP, Karpiouk A, Sokolov K, Emelianov S (2009) Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett 9:2825–2831
Beziere N, Lozano N, Nunes A, Salichs J, Queiros D, Kostarelos K, Ntziachristos V (2015) Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT). Biomaterials 37:415–424
Proulx ST, Luciani P, Derzsi S, Rinderknecht M, Mumprecht V, Leroux JC, Detmar M (2010) Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res 70:7053–7062
Jeong HS, Lee CM, Cheong SJ, Kim EM, Hwang H, Na KS, Lim ST, Sohn MH, Jeong HJ (2013) The effect of mannosylation of liposome-encapsulated indocyanine green on imaging of sentinel lymph node. J Liposome Res 23:291–297
Cook JR, Frey W, Emelianov S (2013) Quantitative photoacoustic imaging of nanoparticles in cells and tissues. ACS Nano 7:1272–1280
Lu HD, Lim TL, Javitt S, Heinmiller A, Prud’homme RK (2017) Assembly of macrocycle dye derivatives into particles for fluorescence and photoacoustic applications. ACS Comb Sci 19:397–406
Lu HD, Wilson BK, Lim TL, Heinmiller A, Prud’homme RK (2017) Real-time and multiplexed photoacoustic imaging of internally normalized mixed-targeted nanoparticles. ACS Biomater Sci Eng 3:443–451
D’Addio SM, Saad W, Ansell SM et al (2012) Effects of block copolymer properties on nanocarrier protection from in vivo clearance. J Control Release 162:208–217. https://doi.org/10.1016/j.jconrel.2012.06.020
Tang C, Edelstein J, Mikitsh JL, Xiao E, Hemphill AH, Pagels R, Chacko AM, Prud’homme R (2016) Biodistribution and fate of core-labeled125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP). J Mater Chem B 4:2428–2434. https://doi.org/10.1039/c5tb02172c
Acknowledgments
We would like to acknowledge Yin, Rideout-Gros, and Nghiem for their help with animal care, So for histology, Mikloska and Seerala for MRI, and FUS and Heinmiller for PAI.
Funding
JLF and FSF were funded by TFRI under grant number 1022 and CIHR grant FDN148367. RKP was funded by Princeton SEAS Blaire/Pyne and Old Guard. KH was funded by NIH under grant number R01-EB003268 and CRC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
FSF consults for and receives grant funding from Fujifilm VisualSonics Inc.
Ethical Statement
All experimental procedures were approved by the Animal Care Committee at Sunnybrook Research Institute, University of Toronto.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 284 kb)
Rights and permissions
About this article
Cite this article
Le Floc’h, J., Lu, H.D., Lim, T.L. et al. Transcranial Photoacoustic Detection of Blood-Brain Barrier Disruption Following Focused Ultrasound-Mediated Nanoparticle Delivery. Mol Imaging Biol 22, 324–334 (2020). https://doi.org/10.1007/s11307-019-01397-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-019-01397-4
Key words
- Photoacoustic
- Nanostructures
- Blood-brain barrier
- Focused ultrasound therapy
- Color Doppler
- Fluorescence microscopy